SCI论文全攻略 审稿回复

PAGE25/NUMPAGES25SCI论文全攻略之审稿回复实例发布时间：2011-4-4Tags:

HYPERLINKSCI论文

附1：SCI扩展版和SCI核心版收录期刊的区别

SCI扩展版（以下简称SCIE）和SCI核心版（以下简称SCI）收录期刊还是有区别的，SCI期刊论文全部被SCI收录，SCIE期刊论文只是部分被SCI收录，这就是有的SCIE期刊一年有几百篇论文，却只有几十篇甚至十几篇论文被SCI收录的原因。具体到SCIE期刊上的一篇论文能否被SCI收录，还是要看美国ISI发布的报告，现在科技部信息研究所也公布这一报告，很多图书馆的SCI检索机构也可以查。

不过在国内，很多单位都把SCI期刊论文和SCIE期刊论文一视同仁，只要发表在SCI期刊或SCIE期刊上，该论文都当作SCI收录，这是管理者的无能抑或无为就不得而知了。但就我们单位而言（国内TOP10高校），这两者还是区别对待的，论文是否SCI收录还是看CISI的报告或SCI检索机构的证据。附2：如何回复SCI投稿审稿人意见(1)1.所有问题必须逐条回答。2.尽量满足意见中需要补充的实验。3.满足不了的也不要回避，说明不能做的合理理由。4.审稿人推荐的文献一定要引用，并讨论透彻。以下是本人对审稿人意见的回复一例，仅供参考。续两点经验：1，最重要的是逐条回答，即使你答不了，也要老实交代；不要太狡猾，以至于耽误事；2，绝大部分实验是不要真追加的，除非你受到启发，而想改投另外高档杂志因为你既然已经写成文章，从逻辑上肯定是一个完整的“story”了。国外杂志要求补充实验的，我均以解释而过关。还因为：很少杂志编辑把你的修改稿再寄给当初审稿人的，除非审稿人特别请求。编辑不一定懂你的东西，他只是看到你认真修改，回答疑问了，也就接受了（当然高档杂志可能不是这样，我的经验只限定一般杂志（影响因子1-5）。我常用的回复格式01：Dearreviewer:Iamverygratefultoyourcommentsforthemanuscript.Accordingwithyouradvice,weamendedtherelevantpartinmanuscript.Someofyourquestionswereansweredbelow.1）2）引用审稿人推荐的文献的确是很重要的，要想办法和自己的文章有机地结合起来。至于实验大部分都可以不用补做，关键是你要让审稿人明白你的文章的重点是什么，这个实验对你要强调的重点内容不是很必要，或者你现在所用的方法已经可以达到目的就行了。最后要注意，审稿人也会犯错误，不仅仅是笔误也有专业知识上的错误，因为编辑找的审稿人未必是你这个领域的专家。只要自己是正确的就要坚持。在回复中委婉地表达一下你的意见，不过要注意商讨语气哦！我得回复格式02：DearProfessorxx:Thankyouverymuchforyourletterdatedxxxxxxxxx,andthereferees’reports.Basedonyourcommentandrequest,wehavemadeextensivemodificationontheoriginalmanuscript.Here,heformatsofbothPDFandMSword,foryourapproval.Adocumentansweringeveryquestionfromtherefereeswasalsosummarizedandenclosed.Arevisedmanuscript.withthecorrectionsectionsredmarkedwasattachedasthesupplementalmaterialandforeasycheck/editingpurpose.Shouldyouhaveanyquestions,pleasecontactuswithouthesitate.然后再附上Q/A，基本上嘱条回答，写的越多越好（老师语）。结果修改一次就接收了：）我的回复，请老外帮忙修改了。DearEditor:Thankyouforyourkindletterof“”onNovember**,2005.Werevisedthemanuscript.inaccordancewiththereviewers’comments,andcarefullyproof-readthemanuscript.tominimizetypographical,grammatical,andbibliographicalerrors.Herebelowisourdescriptiononrevisionaccordingtothereviewers’comments.PartA(Reviewer1).Thereviewer’scomment:Theauthors’Answer:2.Thereviewer’scomment:Theauthors’Answer:......

PartB(Reviewer2)1.Thereviewer’scomment:Theauthors’Answer:2.Thereviewer’scomment:Theauthors’Answer:......Manygrammaticalortypographicalerrorshavebeenrevised.Allthelinesandpagesindicatedaboveareintherevisedmanuscript.Thankyouandallthereviewersforthekindadvice.Sincerelyyours,***

如何回复SCI投稿审稿人意见(2)

一个回复的例子(已接收)Majorcomments:1.TheauthorsneedtostrengthentheirresultsbyincludingMMPsecretion,andtran-matrigelmigrationbyapositivecontrolprogenitorcellpopulationi.e.enrichedhumanCD34cellsobtainedfrommobilizedPBL,sincethisisamoreclinicallyrelevantsourceofCD34cellswhichhasalsobeenshowntosecretebothMMP-9andMMP-2(ref.11).CD34enrichedcellsfromsteadystateperipheralbloodwhichalsosecreteMMPsarealsoofinterest.2.Infig1CpleasespecifywhichcelllinerepresentsMMP-negativecells.Thisneedstobeclarified,aswellasabetterexplanationofthemethodoftheprotocol.3.TheELISAresultsarerepresentedas"foldincrease"comparedtocontrol.Instead,wesuggestthatstandardsshouldbeusedandresultsshouldbepresentedasabsoluteconcentrationsandonlythencantheseresultsbecomparedtothoseofthezymography.4.Whendiscussingtheresults,theauthorsshoulddistinguishclearlybetweenspontaneousmigrationvschemotacticmigration.Furthermore,thehighspontaneousmigrationobtainedwithcordbloodCD34cellsshouldbecomparedtomobilizedPBLCD34enrichedcellsanddiscussed.5.TheauthorsclaimthattheclonogenicassaywasperformedtodeterminetheoptimumconcentrationforinhibitionofMMPactivitybyphenanthrolineandantiMMP-9mAb,howevertheyshouldclarifythatthisassaycanonlydeterminethetoxicityoftheinhibitorsandnottheiroptimalinhibitoryconcentrations.Minorcomments:1.Therearemanyspellingandsyntaxerrors,especiallyintheresultsanddiscussion,whichneedcorrection.a.Ofspecialimportance,isthepercentinhibitionofmigration,whichisdescribedaspercentofmigration.i.e.pg7:"MigrationofCBCD34wasreducedto73.3%?"Insteadshouldread"MigrationofCBCD34wasreducedby73.3%?"b.ThedegreesymbolneedstobeaddedtothenumbersinMaterialsandmethods.2.Itwouldbepreferabletocombinefigure1AandB,inordertoconfirmthereliabilityoffig.1Bbyapositivecontrol(HT1080).Answertoreferee1comment:1.MobilizedperipheralbloodisamoreclinicalsourceofCD34+cells,soitisnecessarytocomparetheMMP-9secretionandtrans-migrationabilityofCBCD34+cellswiththatofmobilizedPBCD34+cells.However,wecouldn'tobtainenoughmobilizedPBtoseparatePBCD34+cellsanddeterminetheMMP-9secretionandmigrationability,sowecouldn’tcomplementthestudyonPBCD34+cellsinthispaper.ResultsobtainedbyJanowska-WieczoreketalfoundthatmobilizedCD34+cellsinperipheralbloodexpressMMP-9.Furthermore,Domenech’sstudyshowedthatMMP-9secretionisinvolvedinG-CSFinducedHPCmobilization.Theirconclusionshavebeenaddedinthediscussion.Inourpresentstudy,ourcentralconclusionfromourdataisthatfreshlyisolatedCD34+stem/progenitorcellsobtainedfromCBproduceMMP-9.2.MMP-9negativecellusedinfig1CwasJurkatcell.Inzymographicanalysis,MMP-9wasnotdetectedinthemediumconditionedbyJurkatcell.ToexcludethatthecontaminatingcellsmayplayaroleintheobservedMMP-9production,wescreenedthemediaconditionedbydifferentproportionofCBmononuclearcellswithMMP-9negativecellsbyzymography.Thisresultmaybeconfusion.Actually,onlybydetectingthemediumconditionedby2X105CBmononuclearcells(MNC)/ml(sincethepuritiesofCD34+cellaremorethan90%),itcouldexcludetheMNCrole.Intherevisedmanuscript,weonlydetectedMMP-9activityandantigenlevelinthemediumconditionedby2X105CBmononuclearcells(MNC)/ml.ThereisnoMMP-9secretionbedetectedinthemediumconditionedby2X105CBMNC/ml.ItexcludedthepossibilitythattheMMP-9activityinCBCD34+cellsconditionedmediumisduetothecontaminationbyMNC.3.Inthisrevisedpaper,wehavedetectedtheMMP-9antigenlevelsbyusingcommercialspecificELISAkits(R&DSystem,sensitivity,0.156ng/ml).RecombinantMMP-9fromR&DSystemwasusedasastandard.Theresultsareexpressedintheabsoluteconcentration.Theabsoluteconcentrationresulthasbeenaddedinthepaper.AsshowninFig2,MMP-9levelsweredetectableinbothCBCD34+cellconditionedmediumandBMCD34+cellconditionedmedium.However,MMP-9levelwassignificantlyhigherinCBCD34+cellconditionedmediumthaninBMCD34+cellconditionedmedium(0.406±0.133ng/mlversus0.195±0.023ng/ml).AlthoughgelatinolyticactivitywasnotdetectedinmediaconditionedbyCD34+cellsfromBM,sensitivityofELISAfavorsthedetectionofMMP-9antigenintheBMCD34+.4.Inourstudy,toestablishthedirectlinkbetweenMMP-9andCBCD34+cellsmigration,weonlydeterminedtheroleofMMP-9inspontaneousmigrationofCBCD34+cells,butnotinchemotacticmigration.Actually,regulationofhematopoieticstemcellmigration,homingandanchorageofrepopulationcellstothebonemarrowinvolvesacomplexinterplaybetweenadhesionmolecules,chemokines,cytokinesandproteolyticenzymes.ResultsobtainedbythegroupsofVoermansrevealthatnotonlythespontaneousmigrationbutalsotheSDF-1inducedmigrationofCBCD34+cellsisgreatlyincreasedincomparisontoCD34+cellsfromBMandperipheralblood.5.CD34+cellsweobtainedineachcordbloodsamplewereverylimited.Itisnotenoughtoscreentheinhibitorsconcentrationstoselecttheoptimalinhibitoryconcentrations.Intheblockingexperiments,basedontheconcentrationsusedbyothersandthemanufacturer'srecommendation,wethendeterminedtheinhibitorsconcentrationsbyexcludingthetoxicityoftheinhibitorsinthatconcentration,whichwasdeterminedbyclonogenicassay.Minorcomments:1.Thespellingandsyntaxerrorshavebeencheckedandcorrected.2.Sincetheresultsinfigure1AandBwereobtainedfromtwoseparatedandparallelexperiments,itisnotfitnesstocombinetwofigures.这是我的一篇修稿回复，杂志是JBMR-A，影响因子3.652，已发表。供参考！ReplytothecommentsonJBMR-A-05-0172Comment:Reference#10ismissingfromtheIntroductionbutusedmuchlaterinthemanuscript.Shouldthesebeinorderusedinmanuscript?Reply:Themissingreferencehasbeenaddedintotherevisedmanuscript.Comment(continued):Whatisthesamplesizeforalltestsperformed?Reply:ThesamplesizefordrugreleaseandPCLdegradationtestswas3.0×3.0cm2,withathicknessofabout0.1mmandaweightofabout40mg.Thisdadahavebeenaddedintotherevisedmanuscript.Comment(continued):Figure7.ThereisnoscientificevidencepresentedintheTEMfiguretoconvincethisreviewerofsub-jets.ThisstatementonPage9cannotbemadewithoutclearevidenceduringthejetformation/separation.Figure7isjustalargefiberandsmallfiberfusedtogether,nootherconclusionthanthiscanbemade.Reply:Necessarychangeinthestatementshasbeenmadeintherevisedmanuscript.aswellasinthereferredfigureaccordingly.Comment(continued):Table3:Needstandarddeviationforallvaluesreportednotjustforaselectfew.EquationafterTable3notnecessary.Justreferencemethodused.Reply:Doneaccordingly.Comment(continued):Page11:"fasterweightloss"Whatwasthesamplesize?Whereisthestatisticalanalysisofthisdata?Thisreviewerdoesnotseeasignificantdifferenceinanyofthedatapresented,thusweightlosswouldbeconsideredequivalent.Reply:Althoughnottoomuchdifferencewasseen,theconclusionthat“theGS/PCLmembraneexhibitedarelativelyfasterweightlosscomparedwiththeRT/PCLmembrane”wasindeedapplicablethrough“one-wayanalysisofvariance(ANOVA)”analysis.Followingthereviewer’scomment,anewsub-sectionhasbeenaddedtothemanuscript.toaddressthestatisticalanalysisforthedata.Comment(continued):Page12:Whatisthesamplesizeforreleasedata?Lookslikeresultsbasedonasamplesizeofone?NeedstanddeviationsonthedatapresentedinFigure11.Whywasn'treleaseperformedandcomparedforallelectrospunconditionsinvestigatedotherwise?Reply:Threerepeatedtestswereperformedforeachsetofmeasurementsandtheresultingdatawereaveraged.Asstatedintherevisedmanuscript,eachsamplehadasquareareaof33cm2withaslightlydifferentthickness.StandarddeviationshavebeenaddedtothedatashowninFig.11.Thepresentmanuscript.aimedtoshowthatmedicaldrugscanbeencapsulatedinultrafinefibersthroughaco-axialelectrospinningprocess.Thedrugreleasedataintendedtoshowthattheencapsulationwassuccessful.Wedidnotconsideranyspecificapplicationinthispreliminarypaper,andinfactthetwodrugswerejustchosenasmodelillustration.Assuch,thereseemednotnecessarytoperform.releaseexperimentsforallofthemembraneselectrospunwithdifferentconditions(i.e.thecoreconcentrations)Comment(continued):Table3:Yang'sorYoung'sModulus(page10saysYoung's).Reply:Correctedaccordingly.Comment(continued):Figure11:Whatisthe%release,notjustconcentration.Whyjustthissmallsampleofreleasedata?Whereisthereleasedatafortheotherconditions?Reply:Unfortunately,wedidnotmeasuretheamountoftheshellmaterialinobtainingthecompositenanofibers.Namely,theflowrateoftheshellsolutionduringtheelectrospinningwasnotaccuratelycontrolledusinganinjectingpump.Hencethe%releasewasnotapplicable.PleaserefertothepreviousreplyrelatedtoPage12andFigure11fortheremainingcomments.Weacknowledgethereviewer’scommentsandsuggestionsverymuch,whicharevaluableinimprovingthequalityofourmanuscript.附3：SCI生物医学英文论文发表成功经验SCI生物医学英文论文发表成功经验共享系列一，（ClinicalChemistry）将自己近10年的科研工作中有关论文整理总结发表方面的一些信息贡献出来，及大家共享！如有时间，我拟将一些已经发表的文章，按照撰写及发表的实际经历及过程，即通过案例分析每一个杂志的特色，审稿偏好，review意见及答复要点等逐一分析。可能包含的杂志系列有：naturemethods，clinicalchemistry，analyticalchemistry，J.Clin.Immuno，Biomed.Microdev，Front.Biosci，Mol.Cell.Biochem，J.Expert，Rev.Proteomics，Jbiochemistry等。本章先讲解美国ClinicalChemistry杂志，一个临床化学界的王牌杂志，近年其影响因子逐年攀升，现为7.7分。ClinicalChemistry由美国AACC每月出版，接受的文章包括及人体疾病相关的实验室研究，分析及分子诊断，仪器，资料处理，数据分析，临床研究等投稿。ISSN：0009-9147网络版ISSN：1530-8561【URL】【镜像URL】【出版者】AmericanAssociationforClinicalChemistry(AACC)【收费情况】免费，全文【内容简介】ClinicalChemistryisaninternationaljournaloflaboratorymedicineandmoleculardiagnostics.ClinicalChemistry--Thishighlyrespectedandoften-citedscientificjournalispublishedmonthlyandcontainspeer-reviewedmethodology,researchpapersandotherarticlesrelevanttoclinicalchemistryandrelatedlaboratorysciences.Itscirculationismorethan15,000.DavidE.Bruns,MD,Editor,(CharlottesvilleOffice)SandraWeaver,SeniorEditorialAssistantDonnaBrandl,EditorialAssistantShaneP.Cyr,EditorialAssistantMacFancher,Publisher,(WashingtonOffice)MiriamGonzalez,PublicationsCoordinator【目录、摘要或全文上网等情况】FreeTOC,1965-FreeAbstract,1975-FreeFulltext,1997-1999Fulltext,1997-

【杂志被索引的情况】IndexedinChemicalAbstracts.【备注】ForfasteraccesstoClinicalChemistryOnlinefromthesecountriesusethisURL:,Brazil,China,France,Germany,HongKong,Ireland,Israel,Italy,Japan,Mexico,Russia,Singapore,SouthAfrica,SouthKorea,Spain,Sweden,Switzerland,Taiwan,TheNetherlands,UK该杂志是由美国临床化学协会（AmericanAssociationforClinicalChemistry，AACC）主办的，于1948年成立，总部位于华盛顿，拥有1万余会员。先在网站注册，登记，按照提示一步步提供文章名称，摘要，作者姓名，所属领域，关键词，主文，图表等等。转换为PDF后就可以提交，然后给你一个查询号，接着就是等待了。。。等了20多天，查阅状态看到了第一次回信：HomeAuthorAreaReviewerAreaPersonalInfo.ClinChemHomeSignOutSubmitNewManuscript.InformationforAuthorsQueueSummaryFeedbackHelpFAQDecisionLetter[ReturntoQueue]To:作者姓名（电子邮件）From:Subject:ClinicalChemistry--Manuscript.DecisionCc:RE:ClinicalChemistryMSID#CLINCHEM/2002/036332TITLE:DearDr.xxx:Yourmanuscript.hasbeenexaminedbytwoexpertreviewers.Pleasevisittoviewtheircomments.Forthereasonsdetailedinthesecomments,wecannotacceptthismanuscript.forpublicationinClinicalChemistryinthisform.Also,yourReference28isnotformattedproperly.OurInformationforAuthorswillofferassistancewithjournalstyle;itcanbefoundatwouldconsiderarevisedversionthattakesthesecriticismsintoaccount.IfyoushouldresubmitthepaperIwouldalsoaskthatyouhaveseveralEnglishspeakingcolleaguesproofthepaperforgrammarandcomposition.Additionally,besuretoprovideadetailedpoint-by-pointresponsetothecommentsofthereviewers.Failuretodosowilldelayconsiderationoftherevisedmanuscript.Priortopublicationwerequirecopyrightreleasessignedbyallauthors.OurAuthorsAssurancesandAssignmentofCopyrightform.canbedownloadedfrom.Pleasenotethatallauthorsmustsignbothsectionsoftheform.(asignatureonthelowersectionmeansthatallconflictsofinteresthavebeendisclosedeveniftherearenone).Sendthecompletedform.tousbyFAX(434-979-7599).Sincerely,Dr.xxxnesleyAssociateEditorP.S.Youwillfindyourrevisedmanuscript.canbeuploadedinyour"SubmitaRevision"queueat.Pleasedonotbeginthesubmissionofyourrevisedmanuscript.untilyouarereadytosubmittheentiremanuscript.Achecklistregardingrequirementsforsubmissioncanbefoundat.FiguresmustbeuploadedasImageFilesin.tifor.epsfilesat600DPI.Alternatively,youmayusePowerPointsoftwareforfiguresbutfontsmustbeembeddedandonlyoneimageperslide,oneslideperfile.Whenuploadingtherevisedversion,pleasebesuretoincludeinthe"ResponsetoReviews"fieldapoint-by-pointlistofallchangesmade,oryourrebuttal,inresponsetoeachofthereviewers?suggestions.P.P.S.Pleasenotethatifyourmanuscript.hascolorfigures,theauthorsareexpectedtobearthecostofprintingthem,exceptinthecaseofinvitedpapers.Thechargesforthesefiguresare$1500forthefirstcolorfigureorpartofafigure,and$500foreachadditionalcolorfigureorpartofafigure.Authorswillbebilledforcolorpublicationcostsunlesstheyrequestthattheirfiguresbeprintedinblackandwhite.该杂志一般为2个审稿人，审稿过程也较严格，都是本领域的大牛。后来我还有幸在一次会议上认识到一个当年的审稿人，但不知道是1还是2，呵呵！一般总是先鼓励一段话，不写了。。。下面问题就来了，共12个，有些很好回答，一句话就可以解释清楚，有些就比较麻烦。还是举例说明把1）实验的有效性和深度（atleastforafewsubstancesofmajorimportancedetectionlimits,cut-offvaluesandspecificityshouldhavebeenstudied.Alsothedescriptionoftheassayprincipleisnotquiteclear）没办法，只有一条路，补充相关实验，然后再投。2）语言问题（TheEnglishtextwouldhavetobesubstantiallyimproved）虽然这是一个美国杂志，但对语言的要求一点都不弱，投之前还是忽略了，没办法，慢慢修改。3）核心的技术问题（Acut-offvalueisgivenforMOLbutthedimensionismissing.Inthediscussionvariousanecdoticreportsaregivenforwhichnodataarepresentedunderresults.）重新验证讨论。本来认为很快就可以接受了，没想到却又等了一个半月（中间发过一次信件询问）才收到回信。原来除了上次2个评委，这次又增加了一个独立审稿人。。。原文如下：Yourrevisedmanuscript.hasbeenexaminedbytheoriginaltworeviewers,plusarecommendedthirdreviewerwithspecialexpertiseinthisarea.Pleasevisittoretrievetheircomments.Thethreereviewersfindmeritinthework,buthavenumerousconstructivesuggestions（别害怕，其实就是几个小问题）.Pleaseconsiderthesesuggestionscarefullyandprepareanimprovedversionthataddressestheseconcerns.Ihavealsonotedthatthereareseveralcolorfiguresincludedinthepaper,whichseemtobeusefulonlyincolor.Pleasebeawarethat(shouldyourpaperbeacceptedforpublication)authorsareexpectedtopaythecostsforpublicationofcolorfigures.Thechargeforthefirstcolorfigureis$1500;subsequentfigures,orpartsoffigures,are$500each.Ofcourse,ifyouwishtosubmitalternatefiguresinblackandwhite(orgrayscale),youmaydoso.Sincerely,Dr.xxxAssociateEditorP.S.Youwillfindyourrevisedmanuscript.canbeuploadedinyour